Patents by Inventor Pierre Billot

Pierre Billot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5800838
    Abstract: The invention is directed to a composition and a method for using the same which composition inhibits or destroys unicellular living organisms. The composition is particularly effective in combating sexually transmitted diseases and as an antiseptic agent. The composition of the invention comprises lithium and ionic or ionizable, fluorine, for example, lithium fluoride. A suitable excipient such as KATHON may also be present.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: September 1, 1998
    Assignee: Atlantic Pharmaceutical Products Limited
    Inventors: Pierre Bourbon, Pierre Lagny, Pierre Billot
  • Patent number: 5762940
    Abstract: This invention relates to a method and composition for inhibiting or destroying viruses or retroviruses in a mammalian host. The method comprises contacting the viruses or retroviruses with a composition. The composition comprises an active ingredient capable of inhibiting or destroying viruses or retroviruses, for example, a surfactant, and an activating ingredient capable of inhibiting or destroying one or more enzymes associated with viruses or retroviruses, for example, a fluorinated compound capable of releasing fluoride anions, and an excipient.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: June 9, 1998
    Assignee: Atlantic Pharmaceutical Products Limited
    Inventors: Pierre Bourbon, Pierre Lagny, Pierre Billot
  • Patent number: 5662941
    Abstract: The invention is directed to a composition and a method for using the same which composition inhibits or destroys unicellular living organisms. The composition is particularly effective in combating sexually transmitted diseases and as an antiseptic agent. The composition of the invention comprises lithium and ionic or ionizable, fluorine, for example, lithium fluoride. A suitable excipient such as KATHON may also be present.
    Type: Grant
    Filed: September 22, 1993
    Date of Patent: September 2, 1997
    Inventors: Pierre Bourbon, Pierre Lagny, Pierre Billot
  • Patent number: 5458889
    Abstract: This invention relates to a method and composition for inhibiting or destroying viruses or retroviruses in a mammalian host. The method comprises contacting the viruses or retroviruses with a composition. The composition comprises an active ingredient capable of inhibiting or destroying viruses or retroviruses, for example, a surfactant, and an activating ingredient capable of inhibiting or destroying one or more enzymes associated with viruses or retroviruses, for example, a fluorinated compound capable of releasing fluoride anions, and an excipient.
    Type: Grant
    Filed: February 22, 1993
    Date of Patent: October 17, 1995
    Assignee: Atlantic Pharmaceutical Products Limited
    Inventors: Pierre Bourbon, Pierre Lagny, Pierre Billot
  • Patent number: 5063064
    Abstract: The invention is directed to a composition and a method for preparing the same which composition inhibits or destroys unicellular living organisms. The composition is effective as a spermicide and also in combating sexually transmitted diseases and as an antiseptic agent. The composition of the invention comprises lithium and ionic or ionizable fluorine, for example, lithium fluoride. A suitable excipient such as KATHON may also be present. The invention may, for example, comprise lithium fluoride and a spermicidal agent, such as a quaternary ammonium compound, for example, benzalkonium chloride.
    Type: Grant
    Filed: September 20, 1988
    Date of Patent: November 5, 1991
    Assignee: Atlantic Pharmaceutical Products Ltd.
    Inventors: Pierre Bourbon, Pierre Lagny, Pierre Billot
  • Patent number: 5026561
    Abstract: The invention relates to a method for inhibiting or destroying unicellular living organisms of a human or animal. The method comprises contacting the unicellular living organisms with the composition which comprises at least one quaternary ammonium salt and which may further comprises a metal fluoride for example, lithium fluoride. A preservative, such as Kathon (Registered Trademark) may also be present in the composition. The method is useful in inhibiting or destroying unicellular living organisms such as viruses or retroviruses, fungi, bacteria, or organisms which cause sexually transmittable diseases. The method may also be used to inhibit or destroy spermatozoa, or inhibit pathogenic microorganisms.
    Type: Grant
    Filed: September 20, 1988
    Date of Patent: June 25, 1991
    Assignee: Atlantic Pharmaceutical Products Limited
    Inventors: Pierre Bourbon, Pierre Lagny, Pierre Billot
  • Patent number: 4917901
    Abstract: The inventive composition comprises an active ingredient, for example a quaternary ammonium compound, which active ingredient is capable of inhibiting or destroying a unicellular living organism, such as spermatazoa, bacteria or virus. The active ingredient is combined in a synergistic amount with an activating ingredient capable of inhibiting or destroying the enzymes associated with the unicellular organism. The activating ingredient may be capable of releasing fluoride ions, for example, an inorganic fluoride compound. The composition according to the invention is useful, for example, as a spermicide, or as an antibiotic, or as an anti-STD preparation for local or topical application.
    Type: Grant
    Filed: May 22, 1987
    Date of Patent: April 17, 1990
    Assignee: Atlantic Pharmaceutical Products, Ltd.
    Inventors: Pierre Bourbon, Pierre Lagny, Pierre Billot